Barbara Weber - 01 Sep 2023 Form 4 Insider Report for Revolution Medicines, Inc. (RVMD)

Role
Director
Signature
/s/ Jack Anders, as Attorney-in-fact for Barbara Weber
Issuer symbol
RVMD
Transactions as of
01 Sep 2023
Net transactions value
-$468,963
Form type
4
Filing time
06 Sep 2023, 20:03:48 UTC
Previous filing
12 Jun 2023
Next filing
05 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVMD Common Stock Options Exercise $4,316 +3,854 +24% $1.12* 19,679 01 Sep 2023 Direct F1, F2
transaction RVMD Common Stock Options Exercise $52,721 +11,146 +57% $4.73* 30,825 01 Sep 2023 Direct F1, F2
transaction RVMD Common Stock Sale $526,000 -15,000 -49% $35.07 15,825 01 Sep 2023 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RVMD Stock Option (Right to Buy) Options Exercise $0 -3,854 -29% $0.000000 9,635 01 Sep 2023 Common Stock 3,854 $1.12 Direct F1
transaction RVMD Stock Option (Right to Buy) Options Exercise $0 -11,146 -86% $0.000000 1,851 01 Sep 2023 Common Stock 11,146 $4.73 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 14, 2022.
F2 Includes 5,200 restricted stock units.
F3 The transaction was executed in multiple trades in prices ranging from $35.00 to $35.24, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.